Results 181 to 190 of about 7,260 (206)
Some of the next articles are maybe not open access.
Latanoprost (Xalatan®) induziertes Makulaödem
Klinische Monatsblätter für Augenheilkunde, 1998BACKGROUND: Latanoprost represents a new therapeutic option in the treatment of chronic open angle glaucoma. It has only recently been reported for the first time that latanoprost caused cystoid macular edema in pseudophakic patients. CASE REPORT: A 60-year-old pseudophakic patient who suffered from a 10-year history of glaucoma, revealed a cystoid ...
Alexander Reis +2 more
openaire +2 more sources
Latanoprost-Loaded Phytantriol Cubosomes for the Treatment of Glaucoma.
European Journal of Pharmaceutical Sciences, 2021C. Bessone +5 more
semanticscholar +1 more source
Journal of dermatological treatment (Print), 2018
Background: Alopecia areata (AA) is one of the most common causes of localized hair loss. There is no universally proven therapy that induces and sustains remission of hair growth in AA.
A. El-Ashmawy +2 more
semanticscholar +1 more source
Background: Alopecia areata (AA) is one of the most common causes of localized hair loss. There is no universally proven therapy that induces and sustains remission of hair growth in AA.
A. El-Ashmawy +2 more
semanticscholar +1 more source
Effects of latanoprost on rodent intraocular pressure
Experimental Eye Research, 2006The aim of the present study was to evaluate the effects of the prostaglandin F2 alpha analog, latanoprost, on the intraocular pressure (IOP) in rodent eyes. Rodents have been increasingly used in glaucoma research; however, conflicting results regarding the actions of prostaglandins on rodent IOP have been published.
N. Andy Whitlock +3 more
openaire +2 more sources
Latanoprost and Hyperpigmentation of Eyelashes
Archives of Ophthalmology, 1997Latanoprost (Xalatan, Pharmacia Upjohn Co, Kalamazoo, Mich) is the first new class of antiglaucoma medication introduced in 20 years. Initial reports about its ocular hypotensive effects seem to be promising, but it has an intriguing side effect of increasing iris pigmentation.
openaire +2 more sources
Latanoprost Versus Combined Timolol and Dorzolamide
Survey of Ophthalmology, 2002We reviewed available data comparing latanoprost and combined timolol and dorzolamide and the additive effect of latanoprost in patients receiving timolol and dorzolamide in combination using a literature search through the electronic Medline database and presentations from proceedings of recent glaucoma meetings.
Bron, Alain, M., Emmerich, Karl-Heinz
openaire +5 more sources
The Effect of Latanoprost on Circadian Intraocular Pressure
Survey of Ophthalmology, 2002The presence of a circadian variation of both intraocular pressure (IOP) and aqueous humor flow has been demonstrated in several studies. It must therefore be considered important to monitor IOP and evaluate the efficacy of ocular hypotensive drugs over the 24 hours of the day.
L. I. Larsson +4 more
openaire +3 more sources
Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness
Cutaneous and Ocular Toxicology, 2019Purpose: To investigate the acute effects of brinzolamide, betaxolol, and latanoprost (drugs commonly used in the medical management of glaucoma) on choroidal thickness using enhanced depth imaging optical coherence tomography (EDI-OCT).
Murat Okutucu +2 more
semanticscholar +1 more source
Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata
Contact Dermatitis, 2019Latanoprost is a phenyl-substituted analogue of prostaglandin F2α used to treat glaucoma (1). Recently, it has been shown to stimulate eyelash hypertrichosis and therefore it has been proposed as a possible treatment for alopecia (2).
M. Napolitano +5 more
semanticscholar +1 more source